|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Company details: Hospira, Inc.
Group companies: Hospira, Inc.
| Name | Category and Sector |
|---|---|
Hospira UK Ltd.
 Hospira UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products |
Pharmaceuticals: Major
|
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| -1.67% | +1.32% | +21.39% | +40.96% | 345B | |
| -1.22% | +0.24% | +11.12% | +34.28% | 274B | |
| -0.94% | -1.87% | -5.71% | +11.00% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| Average | +0.27% | -0.48% | +27.73% | +59.10% | 420.89B | |
| Weighted average by Cap. | +0.13% | +0.04% | +31.41% | +70.15% |
- Stock Market
- Stocks
- Stock
- Company Hospira, Inc.
Select your edition
All financial news and data tailored to specific country editions
